2017
DOI: 10.1016/j.jpba.2017.02.016
|View full text |Cite
|
Sign up to set email alerts
|

Corrigendum to “Application of Analytical Quality by Design concept for bilastine and its degradation impurities determination by hydrophilic interaction liquid chromatographic method” [J. Pharm. Biomed. Anal. 125 (2016) 385–393]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…As a result, it was highlighted that the acetonitrile content in the MP exerted the most significant impact on retention behavior of the analytes. Later, these authors have proposed 155 the integration of a Box−Behnken design with QbD principles for the determination of bilastine and its degradation impurities by HILIC using a cross-linked diol column. MLR was applied to relate the three MP-related parameters to the selectivity factor of the critical peak pairs and minimal analysis run time.…”
Section: ■ Prediction Of Retention In Hilicmentioning
confidence: 99%
“…As a result, it was highlighted that the acetonitrile content in the MP exerted the most significant impact on retention behavior of the analytes. Later, these authors have proposed 155 the integration of a Box−Behnken design with QbD principles for the determination of bilastine and its degradation impurities by HILIC using a cross-linked diol column. MLR was applied to relate the three MP-related parameters to the selectivity factor of the critical peak pairs and minimal analysis run time.…”
Section: ■ Prediction Of Retention In Hilicmentioning
confidence: 99%
“…Furthermore, bilastine has nearly no affinity toward muscarinic and serotonergic receptors [4]. The chemical structure and formula of bilastine are shown in Figure 1 [5].…”
Section: Introductionmentioning
confidence: 99%
“…Being a drug of increasing use, for which there are known a scarce number of analytical tools for its determination in pharmaceutical products and in biological fluids, it becomes important to develop and validate novel, rapid and accurate methodologies for the quantification of bilastine in areas, like the quality control of pharmaceutical preparations and clinical control of BIL takers. Among the well-described analytical methods for bilastine determination are included very few chromatographic methods [7,[11][12][13], which are effective but relatively time consuming and expensive, and simpler spectrophotometric methods based on molecular absorbance detection in the UV region [14,15].…”
Section: Introductionmentioning
confidence: 99%